WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by their role in targeting DNA repair vulnerabilities. Promising candidates, such as NDI-219216, GSK4418959, HRO761, and RO7589831, are in […]
The chronic progressive multiple sclerosis market size is anticipated to grow during the forecast period (2025–2034). According to DelveInsight’s analysis, this growth is expected to be driven by the rising diagnosed prevalence of progressive forms […]
The chronic progressive multiple sclerosis market size is anticipated to grow during the forecast period (2025–2034). According to DelveInsight’s analysis, this growth is expected to be driven by the rising diagnosed prevalence of progressive forms […]
The atypical teratoid/rhabdoid tumor market growth is driven by rising molecular diagnosis and increased awareness of this aggressive pediatric CNS cancer, which is expanding the pool of identified patients. Additionally, the launch of emerging therapies […]
The basal cell nevus syndrome market is expected to witness steady growth driven by increasing awareness, advances in targeted therapies, and the development of novel hedgehog pathway inhibitors. Additionally, the expected launch of emerging therapies […]
